Fixed combination of rivaroxaban and Aspirin: Tablet formulation and analytical method validation

Fixed combination of rivaroxaban and Aspirin: Tablet formulation and analytical method validation

Rivaroxaban and aspirin are commonly used antithrombotic agents in combination to prevent coronary artery disease (CAD) and atherothrombotic events in adult patients after acute coronary syndrome (ACS) with elevated cardiac biomarkers, or with coronary artery disease (CAD) or symptomatic peripheral...

Cijeli opis

Bibliografski detalji
Glavni autori: Hani Naseef, Mosab Afaneh, Moammal Qurt, Abdullah Rabba, Abdallah Abukhalil, Numan Malkieh, Maher Kharouf, Ramzi Moqadi
Format: Članak
Jezik:English
Izdano: Elsevier 2024-08-01
Serija:Talanta Open
Teme:
Rivaroxaban
Aspirin
Fixed-dose combination
Validation
Rp HPLC method
Online pristup:http://www.sciencedirect.com/science/article/pii/S2666831924000122

Internet

http://www.sciencedirect.com/science/article/pii/S2666831924000122

Slični predmeti